Department of Medicine, Hennepin Healthcare, 730 South 8th Street, Minneapolis, MN, 55415, USA.
Department of Internal Medicine, University of Maryland Medical Center Midtown Campus, 827 Linden Ave, Baltimore, MD, 21201, USA.
Crit Care. 2024 May 7;28(1):150. doi: 10.1186/s13054-024-04938-8.
Prior assessments of critical care outcomes in patients with cirrhosis have shown conflicting results. We aimed to provide nationwide generalizable results of critical care outcomes in patients with decompensated cirrhosis.
This is a retrospective study using the National Inpatient Sample from 2016 to 2019. Adults with cirrhosis who required respiratory intubation, central venous catheter placement or both (n = 12,945) with principal diagnoses including: esophageal variceal hemorrhage (EVH, 24%), hepatic encephalopathy (58%), hepatorenal syndrome (HRS, 14%) or spontaneous bacterial peritonitis (4%) were included. A comparison cohort of patients without cirrhosis requiring intubation or central line placement for any principal diagnosis was included.
Those with cirrhosis were younger (mean 58 vs. 63 years, p < 0.001) and more likely to be male (62% vs. 54%, p < 0.001). In-hospital mortality was higher in the cirrhosis cohort (33.1% vs. 26.6%, p < 0.001) and ranged from 26.7% in EVH to 50.6% HRS. Mortality when renal replacement therapy was utilized (n = 1580, 12.2%) was 46.5% in the cirrhosis cohort, compared to 32.3% in other hospitalizations (p < 0.001), and was lowest in EVH (25.7%) and highest in HRS (51.5%). Mortality when cardiopulmonary resuscitation was used was increased in the cirrhosis cohort (88.0% vs. 72.1%, p < 0.001) and highest in HRS (95.7%).
One-third of patients with cirrhosis requiring critical care did not survive to discharge in this U.S. nationwide assessment. While outcomes were worse than in patients without cirrhosis, the results do suggest better outcomes compared to previous studies.
先前对肝硬化患者重症监护结局的评估结果相互矛盾。我们旨在提供全国范围内失代偿期肝硬化患者重症监护结局的可推广结果。
这是一项回顾性研究,使用了 2016 年至 2019 年的国家住院患者样本。纳入了需要进行呼吸插管、中心静脉导管放置或两者皆需(n=12945)的肝硬化成年人,主要诊断包括:食管静脉曲张出血(EVH,24%)、肝性脑病(58%)、肝肾综合征(HRS,14%)或自发性细菌性腹膜炎(4%)。还纳入了一组无肝硬化但因任何主要诊断而需要插管或中央线放置的对照患者。
肝硬化患者年龄较小(平均 58 岁 vs. 63 岁,p<0.001),男性比例更高(62% vs. 54%,p<0.001)。肝硬化组的院内死亡率更高(33.1% vs. 26.6%,p<0.001),EVH 为 26.7%,HRS 为 50.6%。在使用肾脏替代治疗的患者中(n=1580,12.2%),肝硬化组的死亡率为 46.5%,而其他住院患者为 32.3%(p<0.001),EVH 最低(25.7%),HRS 最高(51.5%)。在使用心肺复苏的患者中,肝硬化组的死亡率增加(88.0% vs. 72.1%,p<0.001),HRS 最高(95.7%)。
在这项美国全国性评估中,需要重症监护的肝硬化患者中有三分之一未能存活出院。虽然结果比无肝硬化患者更差,但结果确实表明比以前的研究要好。